These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 19282536)
1. Taking the stress out of acne management. Laubscher T; Regier L; Jin M; Jensen B Can Fam Physician; 2009 Mar; 55(3):266-9. PubMed ID: 19282536 [No Abstract] [Full Text] [Related]
2. Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne. Seidler EM; Kimball AB J Am Acad Dermatol; 2011 Oct; 65(4):e117-e119. PubMed ID: 21816505 [No Abstract] [Full Text] [Related]
10. Combination topical therapy in the treatment of acne. Del Rosso JQ Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494 [TBL] [Abstract][Full Text] [Related]
11. Systemic exposure to benzoic acid and hippuric acid following topical application of clindamycin 1%/benzoyl peroxide 3% fixed-dose combination gel in Japanese patients with acne vulgaris. Ino H; Takahashi N; Saenz AA; Wakamatsu A; Hashimoto H; Nakahara N; Hasegawa S Clin Pharmacol Drug Dev; 2015 Jan; 4(1):18-24. PubMed ID: 27128000 [TBL] [Abstract][Full Text] [Related]
12. Letter to the editor: comparative efficacy and safety of clindamycin phosphate/benzoyl peroxide and adapalene/benzoyl peroxide in acne treatment: a systematic review and meta-analysis of randomized controlled trials. Sesgundo JA; Borra UR; Teslim AA; Hikal H; Qammar A; Adams D; Serag I Arch Dermatol Res; 2024 Sep; 316(8):595. PubMed ID: 39225838 [No Abstract] [Full Text] [Related]
13. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903 [TBL] [Abstract][Full Text] [Related]
14. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176 [TBL] [Abstract][Full Text] [Related]
15. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725 [TBL] [Abstract][Full Text] [Related]
16. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options. Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495 [TBL] [Abstract][Full Text] [Related]
17. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259 [TBL] [Abstract][Full Text] [Related]
18. The effect of vehicle formulation on acne medication tolerability. Draelos ZD; Callender V; Young C; Dhawan SS Cutis; 2008 Oct; 82(4):281-4. PubMed ID: 19055172 [TBL] [Abstract][Full Text] [Related]
19. The treatment of acne: a contemporary review. Schachner L Pediatr Clin North Am; 1983 Jun; 30(3):501-10. PubMed ID: 6224127 [No Abstract] [Full Text] [Related]